IDSA urges Congress to include funding to address shortage of ID clinicians in its FY 2027 bill
Last Updated
June 04, 2026
Early information on the FY 2027 House HHS funding bill includes encouraging signs, including increased investments in infectious diseases research, efforts to combat antimicrobial resistance and the health workforce. We urge Congress to include funding for the Bio-Preparedness Workforce Pilot Program to address the growing shortage of ID clinicians. IDSA eagerly awaits full bill details and urges Congress to reject any funding cuts to programs vital to the nation’s health.
About IDSA
The Infectious Diseases Society of America is a global community of 13,000-plus clinicians, scientists and public health experts working together to solve humanity’s smallest and greatest challenges, from tiny microbes to global outbreaks. Rooted in science, committed to health equity and driven by curiosity, our compassionate and knowledgeable members safeguard the health of individuals, our communities and the world by advancing the treatment and prevention of infectious diseases. Visit idsociety.org to learn more.
Media Contacts
- McCabe Message Partners
- Jen Morales, Senior Director, Public Relations & Marketing, IDSA
- Felicity Clancy, Vice President, Marketing & Communications, IDSA